PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1070392
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1070392
The Gene Amplification market is estimated to be worth $4,560.1 million in 2020. Gene Amplification market is expected to expand at a 16.7% CAGR during the forecast period.
Market Introduction
Gene amplification is the process of increasing the number of copies of a gene sequence. In response to signals from other cells or the environment, cancer cells may create numerous copies of genes. Gene amplification is a process of alteration of genes in cancer, and several oncogenes have been found in amplified regions in the past. New cancer-associated genes may still be discovered in the expanded regions in this regard. Co-amplified genes also contribute to cancer in tandem with known oncogenes in the same amplicons. Gene amplification is an effective mechanism to increase carcinogenesis, given that cancer grows through the change of many genes. The discovery of cancer-related genes could lead to the development of new and effective treatment targets.
Market Dynamics
Human Genome Projects is one of the key growth drivers for the gene amplification technology market. The sequencing of all the chemical base pairs that make up the DNA of the species Homo sapiens is part of an international collaborative research endeavor. Molecular diagnostics, which helps identify specific sequences in DNA or RNA to see if they are connected with any disease, is another important development driver. Oncology, coagulation, genetic disease screening, infectious illnesses, pharmacogenomics, and human leukocyte antigen typing are some of the clinical applications. The market for gene amplification technology is likely to further grow significantly with advances in clinical diagnostic tools.
Pharmaceutical and biotechnology companies have increased their investment in genomics which will further propel the market growth significantly. The biotechnology industry has seen a considerable shift toward novel pharmaceuticals and therapies, sequencing-based medicines, and technological improvements in recent years, resulting in market growth. The use of gene multiplication techniques in the market has been affected by advances in molecular diagnostic tools and sequencing techniques such as Next-generation sequencing techniques and digital PCR in terms of reproducibility, accuracy, and timeliness.
Segmentation Analysis
The Gene Amplification Market is segmented by technology, application, regional distribution, and competitive landscape. Based on application, food safety and agri-diagnostics segments are expected to register the fastest growth at 8.9% during the forecast period. In both industrialized and developing countries, foodborne infections are becoming a rising public health concern. Changing business needs as a result of regulations, as well as rising food consumption patterns, are driving demand for improved and quick, and effective food safety diagnostics. The principal food safety testing technologies used are rapid screening methods such as PCR IMS, immunoassay, and ELISA-based approaches, as well as classic methods such as cultural enrichment and selective agar method.
Competitive Landscape
The Gene Amplification market is fairly concentrated, due to the existence of big players operating on a national and international level. Because of the increasing research and development in the molecular diagnostic field and forensic science coupled with an increasing focus on animal husbandry, environmental monitoring has resulted in increased demand for advanced gene amplification technologies. Some of the key players in the market include QIAGEN, Illumina Inc., Silicon Biosystems, New England Biolabs, Bio-Rad Laboratories, Danaher Corporation, and Merck KgaA, among others.
Key features of the study:
This proposed research study on Gene Amplification market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2021-2027), considering 2020 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Gene Amplification market.
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Gene Amplification market.
Impact of COVID-19 on Gene Amplification market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Gene Amplification market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Gene Amplification market, we have also included competitive landscape and key innovator analysis for the Gene Amplification market
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Gene Amplification market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The Gene Amplification market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
Gene Amplification Market Key Players
QIAGEN
Illumina Inc.
Silicon Biosystems
New England Biolabs
Bio-Rad Laboratories
Merck KGaA
Yikang Gene
Takara Bio Inc.
Danaher Corporation
Promega Corporation
LGC Group
MyBioSource
4basebio AG
Vazyme Biotech Co. Ltd.
Gene Amplification Market by Technology
Isothermal DNA Amplification
Target Amplification
Signal Amplification
Cycling Temperature DNA Amplification
Exponential Gene Amplification
Isothermal Signal Amplification
Cycling Temperature Signal Gene Amplification
Linear Gene Amplification
Gene Amplification Market by Application
Medical Applications
Food safety & Agri Diagnostics
Identity
Forensics
Paternity
Veterinary
Gene Amplification Market by Region
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa